Selenium in the Treatment of Complicated Lymphatic Malformations

PHASE1

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The investigators chose to terminate the study due to participant attrition. Of the limited data evaluable, none of the patients experienced adverse events.

Conditions

Lymphatic Malformations

Interventions

DRUG: Selenium

Sponsor

Medical College of Wisconsin